Stocks and Investing Stocks and Investing
Fri, May 26, 2023

Andrew Fein Reiterated (ZNTL) at Strong Buy and Held Target at $55 on, May 26th, 2023


Published on 2024-10-28 04:02:57 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $55 on, May 26th, 2023.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Bradley Canino of "Stifel" Maintained at Strong Buy and Held Target at $45 on, Tuesday, May 23rd, 2023
  • Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $70 on, Friday, May 19th, 2023
Contributing Sources